In addition, H-FABP is also mentioned as a novel biomarker that has the ability to predict the diagnosis and prognosis of peripheral arterial disease (PAD), by measuring H-FABP and other biomarkers in 1200 patients with PAD and non-PAD using ELISA. This evidence concerns the gene FABP3 and peripheral arterial disease.